Analyst Ratings for Spectrum Pharmaceuticals (SPPI)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 3 / 10
Percentile Rank: 26%
Rating Score: 3 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/26/2023 | H.C. Wainwright | Edward White | Downgrade | Neutral (Buy) |
N/A (N/A) |
0.92 (1.03) |
11.96% | Details |
| 4/26/2023 | Citizens | Reni J. Benjamin | Downgrade | Market Perform (Market Outperform) |
N/A (N/A) |
0.69 (1.03) |
49.28% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


